AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2020 Issue 4; New/Revised ICD-10-CM Codes

Transfusion Stem Cell Progenitor Cells

In the Administration section, at table 302, Circulatory body system, Transfusion, a new substance value has been added for Hematopoietic Stem/Progenitor Cells, Genetically Modified. Body System Approach Function/Device Qualifier 3 Peripheral Vein 4 Central Vein 0 Open 3 Percutaneous C Hematopoietic Stem/Progenitor Cells, Genetically Modified 0 Autologous The new codes will allow the reporting of the administration of genetically modified hematopoietic stem cell treatments, including based gene therapies such as OTL-101. OTL-101, the first ex vivo autologous CD34+ hematopoietic stem cell progenitor cells (HSPC) based gene therapy (HSPC-GT) available for use in the US, is intended for the treatment...

To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .


  • The official AHA publication for ICD-10-CM and ICD-10-PCS coding guidelines and advice
  • Current newsletters added each quarter
  • Full Archives - over 3100 articles
  • ALL years/issues back to 1984 organized by year and issue
  • Includes ICD-10-CM/PCS Articles since 2013
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - ICD-10-CM/PCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.